FDA Adverse Event Injury Summary report: N

ACUITY

MDR report key: 2173856 · Received July 24, 2011

Report

Report Number
2124215-2011-10726
Event Type
Injury
Date Received
July 24, 2011
Date of Event
June 17, 2011
Report Date
July 28, 2011
Manufacturer
CPI - DEL CARIBE
Product Code
OJX
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

FOLLOWING RETURN AND COMPLETION OF LAB ANALYSIS, A FOLLOW-UP REPORT WILL BE SUBMITTED.

Additional Manufacturer Narrative · 1

ADDITIONAL INFORMATION REPORTED THE LEAD WAS DISCARDED AT THE MEDICAL FACILITY AND THUS WILL NOT BE RETURNED FOR A POST MARKET EVALUATION TO ASSESS ROOT CAUSE. IF NEW INFORMATION IS RECEIVED, A FOLLOW-UP REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT WITH THIS LEFT VENTRICULAR LEAD WAS HOSPITALIZED FOR AN EVALUATION. THE MEDICAL ASSESSMENT CONFIRMED LOSS OF CAPTURE AT MAXIMUM OUTPUTS AND THE PHYSICIAN SUSPECTED THE LEAD HAD DISLODGED. TO DATE, THE PATIENT REMAINS HOSPITALIZED FOR A PLANNED REVISION. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. SUBSEQUENTLY, SURGICAL INTERVENTION CONFIRMED A FRACTURED LEAD. THE PRODUCT WAS EXPLANTED IN THE ABSENCE OF ADVERSE EFFECTS AND ANOTHER BOSTON SCIENTIFIC LEAD SUCCESSFULLY IMPLANTED. THE EXPLANTED LEAD IS INTENDED TO BE RETURNED FOR A POST MARKET EVALUATION.

Description of Event or Problem · 1

--

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACUITY IMPLANTABLE HF LEAD OJX CPI - DEL CARIBE 4592

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention